Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study.
Junyan WuJianxiang HuangJianhong ZhuZhichao HeMengting ChenSiyuan GaoDan LiangXiaoxia YuChengyu LuPublished in: Expert opinion on drug safety (2022)
ICIs may increase the risk of KTR in organ transplant recipients with cancer.